These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 6306759)
1. Myeloperoxidase-deficient polymorphonuclear leucocytes. (II) Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse. Bendix-Hansen K; Nielsen HK Scand J Haematol; 1983 Jul; 31(1):5-8. PubMed ID: 6306759 [TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase deficient polymorphonuclear leucocytes in leukaemia and allied disorders. Bendix-Hansen K Dan Med Bull; 1988 Dec; 35(6):501-20. PubMed ID: 2851415 [TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-deficient polymorphonuclear leucocytes. (I) Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans. Bendix-Hansen K; Kaspersen Nielsen H Scand J Haematol; 1983 May; 30(5):415-9. PubMed ID: 6304866 [TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-deficient polymorphonuclear leucocytes. Longitudinal study during the preremission--and the remission phase in acute myeloid leukaemia. Comparison to neutrophil alkaline phosphatase (NAP) activity. Bendix-Hansen K Blut; 1986 Apr; 52(4):237-42. PubMed ID: 3008894 [TBL] [Abstract][Full Text] [Related]
5. Abnormal pattern of bactericidal activity of neutrophils deficient in granules, myeloperoxidase, and alkaline phosphatase. Repine JE; Clawson CC; Brunning RD J Lab Clin Med; 1976 Nov; 88(5):788-95. PubMed ID: 185307 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia. Roberson JR; Onciu M; Pounds S; Rubnitz JE; Pui CH; Razzouk BI Pediatr Blood Cancer; 2008 Mar; 50(3):542-8. PubMed ID: 17763467 [TBL] [Abstract][Full Text] [Related]
7. Biochemical comparison of myeloperoxidase of leukemic myeloblasts and normal neutrophilic granulocytes. Morishita K; Asano S; Fujii H; Yokota J; Kodo H; Miwa S J Appl Biochem; 1984; 6(5-6):271-7. PubMed ID: 6100291 [TBL] [Abstract][Full Text] [Related]
8. Acquired neutrophil myeloperoxidase deficiency: an indicator of subclinical activation of blood coagulation? d'Onofrio G; Mancini R; Vallone R; Alfano G; Candido A; Palla M; Mango G Blood Cells; 1983; 9(3):455-66. PubMed ID: 6326898 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic value of the peroxidase index in patients with acute nonlymphoblastic leukemia]. Mariańska B; Apel D; Maj S Acta Haematol Pol; 1990; 21(1):26-31. PubMed ID: 2260407 [TBL] [Abstract][Full Text] [Related]
10. Neutrophil myeloperoxidase: a simple, reproducible technique to determine activity. Kitahara M; Simonian Y; Eyre HJ J Lab Clin Med; 1979 Feb; 93(2):232-7. PubMed ID: 219116 [TBL] [Abstract][Full Text] [Related]
11. Serum and plasma myeloperoxidase, elastase and lactoferrin content in acute myeloid leukaemia. Olsson I; Olofsson T; Ohlsson K; Gustavsson A Scand J Haematol; 1979 May; 22(5):397-406. PubMed ID: 224448 [TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase-deficient polymorphonuclear leucocytes (III): Relation to incidence of infection in acute myeloid leukaemia. Nielsen HK; Bendix-Hansen K Scand J Haematol; 1984 Jul; 33(1):75-9. PubMed ID: 6087443 [TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia. Bendix-Hansen K; Nielsen HK Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of myeloperoxidase positivity of blast cells in acute myeloblastic leukemia without maturation (FAB: M1): an ECOG study. Matsuo T; Cox C; Bennett JM Hematol Pathol; 1989; 3(4):153-8. PubMed ID: 2560775 [TBL] [Abstract][Full Text] [Related]
15. Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals. Ommen HB; Nyvold CG; Braendstrup K; Andersen BL; Ommen IB; Hasle H; Hokland P; Ostergaard M Br J Haematol; 2008 Jun; 141(6):782-91. PubMed ID: 18410450 [TBL] [Abstract][Full Text] [Related]
16. The relationship of myeloperoxidase activity to neutrophil maturity and other hematologic indicators of infection. Kaplow LS Blood Cells; 1986; 12(1):153-65. PubMed ID: 3024763 [TBL] [Abstract][Full Text] [Related]
17. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia. Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995 [TBL] [Abstract][Full Text] [Related]
18. Purification of myeloperoxidase from equine polymorphonuclear leucocytes. Mathy-Hartert M; Bourgeois E; Grülke S; Deby-Dupont G; Caudron I; Deby C; Lamy M; Serteyn D Can J Vet Res; 1998 Apr; 62(2):127-32. PubMed ID: 9553712 [TBL] [Abstract][Full Text] [Related]
19. Use of Myeloperoxidase mRNA in Monitoring Patients With Acute Myelogenous Leukemia for Early Detection of Circulating Blasts. Crisan D; David D Mol Diagn; 1996 Dec; 1(4):313-319. PubMed ID: 10462578 [TBL] [Abstract][Full Text] [Related]
20. Classification of acute non-lymphocytic leukemia according to the distribution picture of peroxidase activity and cell size: correlation between the classification and therapeutic response. Takubo T; Kubota Y; Oguma S; Ueda T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S Blood Cells; 1983; 9(3):501-14. PubMed ID: 6586210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]